News

At 22, Daniel Cressy is making history as Louisiana’s first sickle cell gene therapy patient. The treatment could be a cure ...
Gene therapies hold immense promise for treating sight loss. These therapies use a modified, harmless virus to deliver ...
DELRAY BEACH, FL / ACCESS Newswire / August 12, 2025 / Adolore BioTherapeutics, Inc., ("Company" or "Adolore") announced that ...
The FDA approved labeling changes for elivaldogene autotemcel (eli-cel; Skysona), a one-time gene therapy for patients with ...
Vinay Prasad is returning to his role at the U.S. Food and Drug Administration to resume overseeing vaccine, gene therapy and ...
An interview with Philip Vanek, chief commercialization officer of the International Society for Cell & Gene Therapy (ISCT), ...
An expert discusses how community-based gene therapy administration has broadened treatment options for patients with ...
A research team headed by the University of Zurich has developed a powerful new method to precisely edit DNA by combining ...
After a strong launch for its cancer gene therapy, Ferring Pharmaceuticals is setting the stage for long-term growth.
Haematological cancers are a recognised potential side effect with Skysona and were already mentioned in a boxed warning on ...
The use of artificial intelligence for batch monitoring and digital twin development are redefining process control — ...
A Food and Drug Administration official is getting his job back as the agency’s top vaccine regulator, less than two weeks ...